These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4543927)

  • 1. Distribution of cytembena in rheumatic patients.
    Grafnetterová J; Smahel O; Truhlár P
    Int J Clin Pharmacol; 1973 Nov; 8(3):185-8. PubMed ID: 4543927
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of Cytembena in chronic renal impairment.
    Schück O; Grafnetterová J; Sotorník I
    Neoplasma; 1976; 23(2):161-70. PubMed ID: 947088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The serum levels and renal excretion of Cytembena after different methods of administration (author's transl)].
    König J; Grafnetterová J; Růzicková S; Dvorák O; Reitschlägerová V; Schück O
    Cas Lek Cesk; 1974 Mar; 113(13):388-92. PubMed ID: 4479828
    [No Abstract]   [Full Text] [Related]  

  • 4. [A study of the kinetics of 14C-cytembena after intravenous administration in rabbits using thin-layer autoradiography].
    Havlík I; Janků I
    Cesk Farm; 1983 Sep; 32(7):241-4. PubMed ID: 6688969
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of glycosaminoglycans in rheumatoid cultures and effects of cortisol on it.
    Saarni H; Tammi M; Vuorio E; Penttinen R
    Scand J Rheumatol; 1980; 9(1):11-6. PubMed ID: 6966422
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of incorporation of labelled cyclophosphamide and cytembena into human tumour.
    Jandov A ; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4725516
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of incorporation of labelled cyclophosphamide cytembena into human tumour.
    Jandová A; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4765907
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies of amine nitrogen level and its dynamics in patients with rheumatism].
    Zborovskiĭ AB; Sidorkin VA
    Vopr Revm; 1969; 9(3):46-52. PubMed ID: 5309405
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acid mucopolysaccharides. Value of their urinary determination in rheumatology].
    Acquaviva P; Garrigues JC; Frezet P; Recordier AM
    Mars Med; 1970 Jun; 107(6):467-72. PubMed ID: 4246824
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase I study of cytembena.
    Frytak S; Moertel CG; Schutt AJ; Ahmann DL; Donadio JV; Weinshilboum RM
    Cancer; 1976 Mar; 37(3):1248-55. PubMed ID: 946591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of unexplained excretion of urocanic acid and urocanyl glycine after a histidine loading test.
    Ayalon D; Chayen R; Herzberg M; Menachem H; Neufeld E; Toaff R
    Isr J Med Sci; 1970; 6(4):488-93. PubMed ID: 5472332
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pantothenic acid metabolism in cardiovascular patients with impaired blood circulation].
    Dediunina RS
    Vopr Pitan; 1966; 25(1):66-71. PubMed ID: 5298032
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the laboratory in rheumatology. Uric acid and the interpretation of hyperuricaemia.
    Scott JT
    Clin Rheum Dis; 1983 Apr; 9(1):241-55. PubMed ID: 6603324
    [No Abstract]   [Full Text] [Related]  

  • 14. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy.
    Matĕjková E; Vlastiborová A
    Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.
    Denko CW; Malemud CJ
    Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial occurrence of "palindromic rheumatism"].
    Krarup NB
    Ugeskr Laeger; 1969 Oct; 131(42):1794-6. PubMed ID: 5309921
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disorder of oxidation-reduction processes and some indices of electrolyte metabolism in rheumatism].
    Kruchanitsia MI; Mashkarinets' NS
    Fiziol Zh; 1973; 19(6):837-9. PubMed ID: 4544995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carbohydrate, vitamin C and B1 metabolic indices in rheumatism].
    Pokin'chereda VV; Okhrimovich LM; Zhura II
    Vrach Delo; 1981 Dec; (12):54-6. PubMed ID: 6977239
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal and gastrointestinal excretion of ouabain in dog and man.
    Selden R; Margolies MN; Smith TW
    J Pharmacol Exp Ther; 1974 Mar; 188(3):615-23. PubMed ID: 4816328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.